Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention (Q28221041)

Crossref

https://api.crossref.org/works/10.2165/00019053-200725090-00005

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

12 December 2020

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

12 December 2020

The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trial

1 reference

12 December 2020

A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort

1 reference

12 December 2020

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction

1 reference

12 December 2020

Long-term clopidogrel therapy after percutaneous coronary intervention in PCI-CURE and CREDO: the "Emperor's New Clothes" revisited

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial

1 reference

12 December 2020

Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events

1 reference

12 December 2020

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Short- and long-term prognosis after acute myocardial infarction in men versus women

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.

1 reference

12 December 2020

Stability of time-tradeoff utilities in survivors of myocardial infarction

1 reference

12 December 2020

Markov models in medical decision making: a practical guide.

1 reference

12 December 2020

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

12 December 2020

Cost-effectiveness of clopidogrel vs. aspirin treatment in high-risk acute coronary syndrome patients in Denmark

1 reference

12 December 2020

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden

1 reference

12 December 2020

Quality of life after cerebrovascular stroke: a systematic study of patients' preferences for different functional outcomes.

1 reference

12 December 2020

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study.

1 reference

12 December 2020

[Calculation of costs of stroke, cost effectiveness of stroke units and secondary prevention in patients after a stroke, as recommended by revised CBO practice guideline 'Stroke']

1 reference

12 December 2020

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

1 reference

12 December 2020

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

12 December 2020

Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention

1 reference

12 December 2020